Andere talen Qlife Holding AB

Aandelen

QLIFE

SE0013486552

Vertraagde tijd Nasdaq Stockholm Andere beurzen 16:10:16 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,003 ^SEK	-6,25%		-9,09%	-84,92%

05/04	Qlife plaatst Deense werkmaatschappij in reconstructiemodus	MT
25/03	Qlife uit Zweden lanceert platform voor biomarkertests in Zuid-Korea via potentieel partnerschap	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Qlife Places Danish Operational Company in Reconstruction Mode	05/04
Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure	04/04
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	25/03
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	25/03
Qlife Signs Letter of Intent with Precision Biosensor	25/03
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.	21/03
Qlife Secures Core Patent for Egoo System in EU, UK Markets	23/02
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom	23/02
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology	16/02
Qlife publishes prospectus due to upcoming rights issue of units	09/02
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	09/02
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	09/02
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024	04/02
Bulletin from the extraordinary general meeting in Qlife Holding AB on 16 January 2024	16/01
Notice of extraordinary general meeting in Qlife Holding AB	12/12
Qlife carries out a rights issue of units of approximately SEK 49.5 million	12/12
Qlife collaboration agreement with Hipro biotechnology - potential value of 500 MSEK	07/12
Qlife Enters Collaboration Agreement with Hipro Biotechnology	07/12
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar	04/12
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Qlife Holding AB

Aandelen

QLIFE

SE0013486552

Andere talen

Filters